SPDR Series Trust SPDR S&P Biotech ETF (XBI): Price and Financial Metrics ETF
XBI Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $87.97 | 52-week high | $105.47 |
| Prev. close | $87.89 | 52-week low | $81.14 |
| Day low | $87.85 | Volume | 7,383,800 |
| Day high | $88.86 | Avg. volume | 9,399,127 |
| 50-day MA | $94.81 | Dividend yield | 0.15% |
| 200-day MA | $94.72 |
XBI Stock Price Chart Interactive Chart >
SPDR Series Trust SPDR S&P Biotech ETF (XBI) ETF Bio
The investment objective of the SPDR S&P Biotech ETF is to provide investment results that correspond generally to the total return performance of the S&P Biotechnology Select Industry Index.
XBI ETF Info
| Issuer | State Street Global Advisors |
| Expense Ratio | 0.35% |
| Underlying Index | S&P Biotechnology Select Industry Index |
| Asset Class | Equity |
| Sector | Biotech |
| Assets Under Management (AUM) | 6.12M |
| Net Asset Value (NAV) | $87.88 |
| Options? | Yes |
| Total Holdings | 145 |
XBI Top Holdings
| Symbol | Company | % of Total |
| NBIX | NEUROCRINE BIOSCIENCES INC | 2.73% |
| UTHR | UNITED THERAPEUTICS CORP | 2.49% |
| NTRA | NATERA INC | 2.48% |
| INCY | INCYTE CORP | 2.46% |
| ABBV | ABBVIE INC | 2.45% |
| GILD | GILEAD SCIENCES INC | 2.44% |
| AMGN | AMGEN INC | 2.43% |
| INSM | INSMED INC | 2.41% |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 2.41% |
| PCVX | VAXCYTE INC | 2.37% |
XBI Price Returns
| 1-mo | -2.05% |
| 3-mo | -11.88% |
| 6-mo | -11.03% |
| 1-year | 1.20% |
| 3-year | -5.76% |
| 5-year | N/A |
| YTD | -2.32% |
| 2024 | 1.01% |
| 2023 | 7.60% |
| 2022 | -25.87% |
| 2021 | -20.45% |
| 2020 | 48.33% |
XBI Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||